Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |